Market news Latest

Miami Clinical Research assists Myovant Sciences in achieving impressive results

 Breaking News
  • No posts were found

Miami Clinical Research assists Myovant Sciences in achieving impressive results

August 10
03:33 2019
Miami Clinical Research assists Myovant Sciences in achieving impressive results
Miami Clinical Research is proud to announce that they are now assisting innovative pharmaceutical development company Myovant Sciences achieve top line results from clinical trials.

Miami Clinical Research is proud to announce that they are now assisting innovative pharmaceutical development company Myovant Sciences achieve superior results from clinical trials.

Contributing to Top Line Results in Liberty 1 and Liberty 2 Clinical Trials

Accordingg to WomansHealth.gov around 20-80% of women will develop fibroids by the time they reach age 50. Symptoms often include heavy menstrual bleeding, longer periods, pelvic pain, frequent urination, backache and more.

Moyvant Sciences has focused their Liberty 1 and Liberty 2 clinical trials on evaluating a promising drug, Relugolix in women who suffer from heavy menstrual bleeding as a result of uterine fibroids.

Miami Clinical Research is proud to have supported these Phase III clinical trials in achieving top line results, the outcome of which may help millions of women worldwide suffering from uterine fibroids.

Medical Studies


Medical studies, also referred to as clinical trials, are an invaluable tool medical scientists and pharmaceutical researchers can leverage in order to further medical breakthroughs and develop innovative treatment protocols. Miami Clinical Research makes available both paid medical studies in South Florida, and unpaid medical studies.

Medical studies and clinical trials are designed to collect data used to determine the safety, efficacy and optimal treatment of a patient utilizing a specific drug or therapy. The results of these trials may lead to improved diagnosis, treatment and cures that have the potential to improve and save the lives of millions of individuals worldwide.

Clinical Research Studies

Although some medical studies are observational by design, clinical trials involve the systematic investigation of a subject or subjects while under the care and treatment of a particular drug or therapeutic protocol.

Clinical trials are often randomized and “double blind”, where participants at random, and unbeknownst to the researchers and doctors, receive either the real treatment or a placebo. This strategy eliminates bias and ensures that the data won’t be compromised by the “placebo effect”.

Human trials generally take place in four “phases”, and only after extensive data and information has been collected from animal models demonstrating both promise for the drug as a treatment and a level of safety.

Clinical Research Study Phases Include:

  • Phase I: 20-100 participants
  • Phase II: Approximately 200 participants
  • Phase III: Thousands of patients internationally
  • Phase IV: (Pending approval) Continued monitoring with an increased focus on adverse reactions and side effects in patients


Benefits of Participating In Clinical Trials

Participating in clinical trials offers a myriad of benefits, not only direct to the participant, but potentially for millions of individuals who may benefit from the results of that trial in the future.

Commonly Cited Benefits Include:

  • Benefiting from cutting edge treatments
  • Access to research treatments prior to public availability
  • Free or discounted medical care
  • Opportunity to contribute to the greater good


About Miami Clinical Research

Based out of sunny Miami, Miami Clinical Research was founded with a mission to enhance the quality of health and wellness through medical research. Their team of dedicated and passionate healthcare professionals work tirelessly to further medical and pharmaceutical innovation and treatments having the potential to help millions of patients live a longer better quality of life.

About Myovant Sciences

Headquartered in the United Kingdom, pharmaceutical development and research company Myovant Sciences (MYOV:NYSE) is a company dedicated to purpose-driven science and transformational medicine.

Myovant Sciences paces a specialized focus on addressing unmet needs in woman’s health and prostate cancer, fueled by the opportunity to empower physicians and healthcare professionals with innovative treatments that have the potential to improve the lives of millions of patients impacted by diseases.

Current Areas of Focus Include:

  • Uterine Fibroids
  • Endometriosis
  • Infertility
  • Prostate Cancer

Individuals or medical professionals interested in learning more about Myovant Sciences or Miami Clinical Research and available clinical studies are encouraged to reach out via their official websites or by way of the media contact information below.

Media Contact
Company Name: Miami Clinical Research
Contact Person: Carlos Carus JR.
Email: Send Email
Phone: 305-433-6496
Address:7371 SW 24th street
City: Miami
State: Florida
Country: United States
Website: www.miamiclinicalresearch.com